We are thrilled to welcome Gudrun Trøite to the NaDeNo team as Head of Operations.

Gudrun has 20 years’ drug development experience from the Norwegian biotech industry, including Ultimovacs ASA and Photocure, where she has held various leading roles within clinical operations, regulatory and quality assurance. She has successfully led multi-national studies within various indications through all phases of development, including large pivotal studies leading to regulatory approval.

Gudrun is passionate about streamlining design and management of complex projects to ensure successful conduct and reliable data to support drug development, and her expertise will be of crucial value to the NaDeNo team as our nanotechnology is approaching the clinical development phase.